Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies
暂无分享,去创建一个
C Augood | A Stary | B. Stray-Pedersen | J. Paavonen | I. Russell | P. Mårdh | A. Templeton | A. Stary | J Paavonen | B Stray-Pedersen | A Templeton | I Russell | E Honey | P-A Mårdh | C. Augood | E. Honey
[1] W. Cates,et al. Genital chlamydial infections: epidemiology and reproductive sequelae. , 1991, American journal of obstetrics and gynecology.
[2] M. R. Howell,et al. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. , 1999, Sexually transmitted diseases.
[3] D. Atkins,et al. The U.S. Preventive Services Task Force: putting evidence-based medicine to work. , 1998, Clinical obstetrics and gynecology.
[4] L. Svensson,et al. Screening voided urine for Chlamydia trachomatis in asymptomatic adolescent females , 1994, Acta obstetricia et gynecologica Scandinavica.
[5] F. Skjeldestad,et al. Should asymptomatic patients be tested for Chlamydia trachomatis in general practice? , 1990, The British journal of general practice : the journal of the Royal College of General Practitioners.
[6] T. Greenhalgh. How to read a paper: Papers that tell you what things cost (economic analyses) , 1997 .
[7] K. Tchoudomirova,et al. Prevalence, epidemiological and clinical correlates of genital Chlamydia trachomatis infection 1 , 1998, Journal of the European Academy of Dermatology and Venereology : JEADV.
[8] Trisha Greenhalgh,et al. How to Read a Paper , 1999 .
[9] P. Mårdh,et al. Infertility after acute salpingitis with special reference to Chlamydia trachomatis. , 1983, Fertility and sterility.
[10] T. Ripa. Epidemiologic control of genital Chlamydia trachomatis infections. , 1990, Scandinavian journal of infectious diseases. Supplementum.
[11] Helen H. Lee,et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine , 1995, The Lancet.
[12] A. L. Hillman,et al. Economic Analysis of Health Care Technology: A Report on Principles , 1995, Annals of Internal Medicine.
[13] C. Goldsmith,et al. Effectiveness and efficiency of selective vs universal screening for chlamydial infection in sexually active young women. , 1992, Archives of internal medicine.
[14] H. Sintonen,et al. Cost‐Benefit Analysis of First‐Void Urine Chlamydia trachomatis Screening Program , 1998, Obstetrics and gynecology.
[15] G. Ridgway,et al. Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey , 1997, BMJ.
[16] J. Stephenson. Screening for genital chlamydial infection. , 1998, British Medical Bulletin.
[17] R. Rickard,et al. Cost‐Benefit Analysis of Selective Screening Criteria for Chlamydia trachomatis Infection in Women Attending Colorado Family Planning Clinics , 1992, Sexually transmitted diseases.
[18] M. R. Howell,et al. Screening Women for Chlamydia trachomatis in Family Planning Clinics: The Cost‐Effectiveness of DNA Amplification Assays , 1998, Sexually transmitted diseases.
[19] T. Farley,et al. A School-based Chlamydia Control Program Using DNA Amplification Technology , 1998, Pediatrics.
[20] M. R. Howell,et al. Chlamydia trachomatis infections in female military recruits. , 1998, The New England journal of medicine.
[21] P. Mårdh,et al. A Cost-effectiveness Analysis of Screening and Treatment for Chlamydia trachomatis Infection in Asymptomatic Women , 1996, Annals of Internal Medicine.
[22] K. Holmes,et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. , 1996, New England Journal of Medicine.
[23] M. Lehtinen,et al. Chlamydial pelvic inflammatory disease. , 1996, Human reproduction update.
[24] G A Colditz,et al. Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature , 1992, Annals of Internal Medicine.
[25] J C Jager,et al. Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. , 2000, Sexually transmitted diseases.
[26] S. Keenan,et al. A systematic review of the cost-effectiveness of noncardiac transitional care units. , 1998, Chest.
[27] D. Taylor-Robinson. Chlamydia trachomatis and sexually transmitted disease , 1994, BMJ.
[28] H. Handsfield,et al. Performance and Cost‐Effectiveness of Selective Screening Criteria for Chlamydia trachomatis Infection in Women: Implications for a National Chlamydia Control Strategy , 1997, Sexually transmitted diseases.
[29] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[30] Charlotte Gaydos,et al. Screening for Chlamydia trachomatis in Asymptomatic Women Attending Family Planning Clinics: A Cost-Effectiveness Analysis of Three Strategies , 1998, Annals of Internal Medicine.
[31] L. Bodin,et al. Programmes to reduce pelvic inflammatory disease—the Swedish experience , 1998, The Lancet.
[32] L Weström,et al. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. , 1980, American journal of obstetrics and gynecology.